Enquire about our organoid biobank

Find out how to get access to HUB's patient-derived organoids

Thousands of established models

Multiple disease indications and healthy tissue-derived organoids

HUB Organoid Technology allows to model a range of human pathologies where no other clinically-relevant in vitro disease models are currently available.

Key research areas include:

  • Oncology and immuno-oncology
  • Infectious diseases
  • Genetic disorders such as cystic fibrosis
  • Inflammatory conditions such as IBD and COPD
  • Toxicology

Request access
Patient relevance

Patient-relevant

HUB Organoids™ preserve the original tissue genetic make-up, morphology and pathophysiology, including patient- and disease-specific antigens and mutations.

Stable in long term culture_bigger

Stable in long-term culture

Thanks to proprietary culture conditions that preserve the adult stem cell component, HUB Organoids™ can be maintained in culture indefinitely without compromising their original identity.

1000s available models

1000s models established

Whether you are interested in oncology, genetic disorders such as cystic fibrosis, or inflammatory diseases such as COPD and IBD we got you covered.